Dr Rajesh Jhorawat, MD, DM(Nephrology) - SMS Medical College and Hospital, Jaipur - DM Nephrology

Dr Rajesh Jhorawat

MD, DM(Nephrology)

SMS Medical College and Hospital, Jaipur

DM Nephrology

Jaipur, Rajasthan | India

Main Specialties: Nephrology

Additional Specialties: Nephrology

Top Author

Dr Rajesh Jhorawat, MD, DM(Nephrology) - SMS Medical College and Hospital, Jaipur - DM Nephrology

Dr Rajesh Jhorawat

MD, DM(Nephrology)


Dr. Rajesh Jhorawat did his MBBS from prestigious All India Institute of Medical Sciences (AIIMS) New Delhi, MD from PGI Chandigarh & DM (Nephrology) from SMS Medical College Jaipur.
Dr Jhorawat has Experience in Clinical Immunology (including Transplant Immunology) from SGPGI (Lucknow) & published many papers in index journal. His study & his work have been selected for presentation both in national & international Nephrology Meet.
He is active member of-
Indian Society of Nephrology (ISN)
American Society of Nephrology (ASN)
European Renal Association (ERA - EDTA)
International Society of Nephrology (ISN)

Primary Affiliation: SMS Medical College and Hospital, Jaipur - Jaipur, Rajasthan , India


Additional Specialties:

Research Interests:

View Dr Rajesh Jhorawat’s Resume / CV


Number of Publications



Number of Profile Views


Profile Views

Number of Article Reads



Number of PubMed Central Citations


PubMed Central Citations


Aug 2012
SMS Medical College Jaipur
DM (Nephrology)
Dec 2009
PGIMER Chandigarh
MD (Medicine)
Dec 2005
AIIMS New Delhi


Aug 2011
SGPGI Lucknow
Jan 2010
PGIMER Chandigarh
Jan 2006
AIIMS PSM dedartment




3PubMed Central Citations

Comparison of intradermal route and dose of Hepatitis B vaccine administration in chronic dialysis patients: A pilot study.

Saudi J Kidney Dis Transpl 2018 Mar-Apr;29(2):376-380

Department of Nephrology, SMS Medical College and Hospital, Jaipur, Rajasthan, India.

View Article
April 2018
14 Reads

Preventive role of carvedilol in adriamycin-induced cardiomyopathy

Indian J Med Res 2016 Nov;144:725-729

Indian J Med Res

Background & objectives: Adriamycin though considered as an effective anticancer drug, leads to irreversible cardiomyopathy (CMP) and congestive heart failure (CHF). The aim of this study was to determine the protective effect of carvedilol in adriamycin (ADR)-induced cardiomyopathy (CMP) in cancer patients. Methods: Patients with lymphoreticular malignancy in whom ADR therapy was planned were randomized into two groups: carvedilol and control. Twenty seven patients each were enrolled in carvedilol and control groups. In the carvedilol group, 12.5 mg once daily oral carvedilol was given during six months. The patients were evaluated by echocardiography before and after chemotherapy. Left ventricular ejection fraction (EF) and systolic and diastolic diameters were calculated. Results: At six months of follow up, six patients in the carvedilol group and five in the control group had died. The mean EF (63.19 vs. 63.88%) and fraction shortening (FS) (34 vs. 34.6) of the carvedilol group were similar at follow up, but in the control group, the mean EF (67.27 vs. 60.82%, P=0.003) and FS (38.48 vs. 34.6, P<0.05) at control echocardiography were significantly lower. In carvedilol group, both systolic and diastolic diameters were not changed, but in control group, systolic diameters were significantly increased compared with basal measures (left ventricular end systolic diameter = 28.26±5.50 mm vs. 31.25± 6.50 mm; P< 0.05). Interpretation & conclusions: Prophylactic use of carvedilol in patients receiving anthracycline protected systolic functions of the left ventricle. Carvedilol can be a potential drug which can ameliorate ADRinduced CMP.

View Article
November 2016
20 Reads

Acute kidney injury in patients with Plasmodium vivax malaria: Clinicohistopathological profile

Saudi Journal for Health Sciences. 2016 Sep-Dec;5(3):138-41

Saudi Journal for Health Sciences

Context: There has been an unexplained increase in the number of cases with multiorgan dysfunction including acute kidney injury (AKI), attributed to Plasmodium vivax monoinfection. Only a few case reports in literature have published the renal biopsy findings in these patients. Aims: The aim of this study was to evaluate the clinical and histopathologic profile of patients with P. vivax malaria monoinfection and AKI. Settings and Design: A prospective study was performed in a tertiary care hospital in North‑Western India. Subjects and Methods: The study included patients diagnosed with P. vivax monoinfection on peripheral smear blood films and rapid diagnostic test (positive for P. vivax specific lactate dehydrogenase). AKI was defined based on the WHO criteria for complicated malaria, i.e. serum creatinine >265 μmol/l or 3 mg/dl. The patients were initiated on hemodialysis for persistent hyperkalemia, fluid overload, severe metabolic acidosis, or uremic symptoms. Renal biopsy was performed in the presence of active urinary sediments (proteinuria, hematuria) or persistence of renal failure >14 days. Results: A total of thirty patients fulfilled AKI criteria. The patients with AKI were older (mean age 42.1 ± 10.9 years), male, with a longer duration of illness (mean 12.3 ± 10 days) and associated with multisystem dysfunction. The mean serum creatinine was 7.58 ± 3.2 mg/dl, thrombocytopenia was seen in 47%. Thirty percent had severe anemia requiring a blood transfusion. Renal biopsy was performed in six patients for various indications. The most common pattern was acute tubular necrosis (four patients), followed by acute cortical necrosis (1), and thrombotic microangiopathy (one patient). The complete renal recovery was seen in 24 (80%). Two patients became dialysis‑dependent. Conclusions: AKI associated with P. vivax monoinfection is not rare as previously thought. Therefore, it should be considered in the differential diagnosis of any patient presenting with AKI.

View Article
September 2016
21 Reads

Effect of vitamin D level on the immunogenicity to hepatitis B vaccination in dialysis patients.

Indian J Gastroenterol 2016 Jan 15;35(1):67-71. Epub 2016 Feb 15.

Department of Nephrology, Sawai Man Singh Medical College and Hospital, J L N Marg, Jaipur, 302 004, India.

View Article
January 2016
47 Reads
1 PubMed Central Citation(source)

Plasmodium vivax induced hemolytic uremic syndrome: An uncommon manifestation that leads to a grave complication and treated successfully with renal transplantation.

Trop Parasitol 2015 Jul-Dec;5(2):127-9

Department of Nephrology, SMS Medical College and Hospital, SMS Hospital, Jaipur, Rajasthan, India.

View Article
December 2015
32 Reads

A comparative study of central versus posterior approach for internal jugular hemodialysis catheter insertion.

Indian J Nephrol 2015 Sep-Oct;25(5):265-8

Department of Nephrology, SMS Hospital and Medical College, Jaipur, Rajasthan, India.

View Article
December 2015
14 Reads
1 PubMed Central Citation(source)

Renal cortical necrosis: A rare complication of Plasmodium vivax malaria.

Indian J Nephrol 2014 Nov;24(6):390-3

Professor and Head, Department of Nephrology, SMS Medical College, Jaipur, Rajasthan, India.

View Article
November 2014
37 Reads
1 PubMed Central Citation(source)

Effect of renal transplantation on multiple hormone levels in patients of chronic kidney disease: A single center study

Indian journal of transplantation 2014 July-September 8(3);75-79

Indian journal of transplantation

Aim To assess the level of hormones in chronic kidney disease (CKD) patients and the effect of renal transplantation (RTx) on these hormones. Materials and methods 17 patients enrolled and levels of 11 hormones i.e. FT3, FT4, TSH, FSH, LH, prolactin, testosterone, cortisol, growth hormone, PTH and insulin were measured in every patient before and at 1st, 3rd and 6th month after RTx with correlation to serum creatinine. Patients with underlying endocrine disorders were excluded. Result At 1st and 3rd month of follow up after RTx, there was no statistical significant change in the hormones level except in PTH, which normalised (Pre transplant levels: 262.542 ± 239.706 and 1 month levels: 101.412 ± 66.615 p = 0.024 at 3rd month level: 113.02 ± 95.960 p = 0.036). At 6th month, along with PTH, LH level decreased significantly (LH level pre-RTx 8.387 ± 4.536 and 3.091 ± 2.139 at 6th month p = 0.024). Levels of other hormones also normalised. Mean serum creatinine at 6th month had increased from its nadir level post RTx (1.149 ± 0.164 mg/dl to 1.386 ± 0.323 mg/dl p = 0.034), due to rise of serum creatinine in 4 patients. FT3, cortisol, prolactin and insulin levels also increased in parallel with serum creatinine, however insulin level correlated significantly (r = 0.759 with 95% CI = 0.015–0.962). Conclusion RTx corrects most of the hormonal disturbances in CKD patients, particularly abnormalities in PTH and LH levels in early post transplant period. Even mild allograft dysfunction significantly affects the hormonal levels in a manner which is similar to the changes seen in CKD.

View Article
August 2014
19 Reads